Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.63)
# 3,092
Out of 4,827 analysts
20
Total ratings
33.33%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EMN Eastman Chemical Company | Downgrades: Neutral | $112 → $76 | $77.50 | -1.94% | 4 | Apr 28, 2025 | |
MOS The Mosaic Company | Upgrades: Overweight | $26 → $29 | $32.67 | -11.23% | 4 | Mar 3, 2025 | |
ECL Ecolab | Downgrades: Neutral | $200 → $220 | $252.59 | -12.90% | 5 | Feb 14, 2024 | |
LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $56.93 | +75.65% | 3 | Feb 5, 2024 | |
AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $172.20 | +26.60% | 2 | Feb 1, 2024 | |
LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $734.43 | -78.62% | 2 | Aug 14, 2020 |
Eastman Chemical Company
Apr 28, 2025
Downgrades: Neutral
Price Target: $112 → $76
Current: $77.50
Upside: -1.94%
The Mosaic Company
Mar 3, 2025
Upgrades: Overweight
Price Target: $26 → $29
Current: $32.67
Upside: -11.23%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $252.59
Upside: -12.90%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $56.93
Upside: +75.65%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $172.20
Upside: +26.60%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $734.43
Upside: -78.62%